About Madorra
Madorra is a company based in Portland (United States) founded in 2014 by Holly Rockweiler and Ryan Krone. It operates as a HealthTech. Madorra has raised $4 million across 6 funding rounds from investors including HHS, OneVentures and OTRADI. The company has 6 employees as of December 31, 2022. Madorra offers products and services including Nonhormonal Vaginal Health Device. Madorra operates in a competitive market with competitors including FEMSelect, AVeta Medical, Bioceptive, Pharmiva and Aqueduct Medical, among others.
- Headquarter Portland, United States
- Employees 6 as on 31 Dec, 2022
- Founders Holly Rockweiler, Ryan Krone
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Madorra Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4 M (USD)
in 6 rounds
-
Latest Funding Round
$1.51 M (USD), Grant
Sep 01, 2024
-
Investors
HHS
& 3 more
-
Employee Count
6
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Madorra
Madorra offers a comprehensive portfolio of products and services, including Nonhormonal Vaginal Health Device.
A noninvasive solution for vaginal dryness is provided.
People of Madorra
Unlock access to complete
Unlock access to complete
Funding Insights of Madorra
Madorra has successfully raised a total of $4M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $1.51 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Madorra
Madorra has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, OneVentures and OTRADI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm offering growth equity and credit for technology and healthcare companies.
|
Locked | Locked | Locked | |
|
Bioscience startups are incubated by OTRADI in Portland, Oregon.
|
Locked | Locked | Locked | |
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked |
Investor details for Madorra
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Madorra
Investment portfolio details for Madorra
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Madorra
Detailed financials for Madorra
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Madorra Comparisons
Peer comparison for Madorra
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Madorra
Madorra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as FEMSelect, AVeta Medical, Bioceptive, Pharmiva and Aqueduct Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A minimally invasive surgical system for uterine prolapse is developed.
|
|
| Locked | Locked | Locked |
Non-hormonal device for menopause symptoms is developed using wound-healing process.
|
|
| Locked | Locked | Locked |
Medical devices for gynecological procedures are developed.
|
|
| Locked | Locked | Locked |
Developer of smart medical devices against bacterial vaginosis in women
|
|
| Locked | Locked | Locked |
Develops cervical dilator devices for intrauterine procedures.
|
Detailed competitors of Madorra
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Madorra
Complete news archive for Madorra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madorra
Madorra was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Madorra is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Holly Rockweiler is the current CEO of Madorra. They have also founded this company.
Madorra is a funded company, having raised a total of $4M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Madorra is 6.
Solutions for post-menopausal women and breast cancer survivors are developed by Madorra. A nonhormonal and noninvasive approach to treating vaginal dryness is provided, addressing moderate to severe vulvovaginal atrophy. The healthcare sector, specifically womens health, is targeted with innovative medical devices. Empowerment through choice in vaginal health management is emphasized. Breakthrough device designation status has been received for their primary solution.
Madorra's top competitors include FEMSelect, Bioceptive and AVeta Medical.
Madorra offers Nonhormonal Vaginal Health Device.
Madorra has 4 investors. Key investors include HHS, OneVentures, OTRADI, and America’s Seed Fund.